AstraZeneca, an international biopharmaceutical company, and SKOLKOVO Foundation announced the launch of a joint acceleration program for projects in the area of oncology, cardiovascular, metabolic, kidney, respiratory, and autoimmune diseases.
The scientific partners of acceleration program include National Research Nuclear University MEPhI and Siberian State Medical University.
The goal of Startup Challenge 2018 is to find promising ideas and innovative solutions. Project participants will compete in two categories, including medicinal/biomedical cell products and test systems, hardware solutions and devices for drug delivery.
Source: AstraZeneca and SKOLKOVO launched Startup Challenge 2018 acceleration program
